Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Aeglea BioTherapeutics Inc (was renamed to Spyre Therapeutics (SYRE)) (AGLE)

  • SEC News
  • June 17, 2025, 11:36 UTC

New Form 8-K - Spyre Therapeutics, Inc. Filed: 2025-06-17 AccNo: 0001193125-25-141756 Size: 11 MB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Full text
Register to leave comments
There are no comments here yet...

Search

News categories

  • Technical Exchange News(9560)
  • Event(407)
  • SEC News(156840)
  • FDA Approval(9038)
  • Company Report(721)
  • Business News(106510)
© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin